A series of homo- and hetero-dimetallic complexes of Ir, Rh, and Pd have been obtained using our previously reported Y-shaped tris-NHC ligand. The new complexes can be obtained through the isolation of the corresponding monometallic intermediates (in which the ligand always coordinates in a chelating form) or by a one-pot stepwise synthetic protocol that avoids the isolation of the intermediate. The catalytic properties of the Ir–Pd complexes have been explored in two tandem processes: dehalogenation/transfer hydrogenation of haloacetophenones and Suzuki-coupling/transfer hydrogenation of p -bromoacetophenone. These two complexes have been also tested in two model reactions typically catalyzed by iridium (cyclization of 2-aminophenyl ethyl alcohol to yield indole) and palladium (acylation of bromobenzene with n -hexanal).
No takes yet. Share an insight, caveat, or question.
Gonell et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: